Skip to main navigation Skip to search Skip to main content

Biocompatible Ferrofluid-Based Millirobot for Tumor Photothermal Therapy in Near-Infrared-II Window

  • Yiming Ji
  • , Xue Bai
  • , Hongyan Sun
  • , Luyao Wang
  • , Chunyuan Gan
  • , Lina Jia
  • , Junjie Xu
  • , Wei Zhang
  • , Liang Wang
  • , Yingchen Xu
  • , Yaxin Hou
  • , Yinyan Wang
  • , Hui Hui
  • , Lin Feng*
  • *Corresponding author for this work
  • Beihang University
  • Capital Medical University
  • CAS - Institute of Automation

Research output: Contribution to journalArticlepeer-review

Abstract

Ferrofluidic robots with excellent deformability and controllability have been intensively studied recently. However, most of these studies are in vitro and the use of ferrofluids for in vivo medicinal applications remains a big challenge. The application of ferrofluidic robots to the body requires the solution of many key problems. In this study, biocompatibility, controllability, and tumor-killing efficacy are considered when creating a ferrofluid-based millirobot for in vivo tumor-targeted therapy. For biocompatibility problems, corn oil is used specifically for the ferrofluid robot. In addition, a control system is built that enables a 3D magnetic drive to be implemented in complex biological media. Using the photothermal conversion property of 1064 nm, the ferrofluid robot can kill tumor cells in vitro; inhibit tumor volume, destroy the tumor interstitium, increase tumor cell apoptosis, and inhibit tumor cell proliferation in vivo. This study provides a reference for ferrofluid-based millirobots to achieve targeted therapies in vivo.

Original languageEnglish
Article number2302395
JournalAdvanced Healthcare Materials
Volume13
Issue number4
DOIs
StatePublished - 6 Feb 2024

Keywords

  • biocompatibility
  • ferrofluid robots
  • targeted therapy

Fingerprint

Dive into the research topics of 'Biocompatible Ferrofluid-Based Millirobot for Tumor Photothermal Therapy in Near-Infrared-II Window'. Together they form a unique fingerprint.

Cite this